Ionis Pharmaceuticals

Ionis Pharmaceuticals is a company that operates as an innovator in RNA-targeted therapeutics. The company was designed to create a better, more efficient drug discovery platform, establish a new innovation-centered business model, maximize the value of medicine it creates and gets it to the people who need mostly need it as fast and efficient as possible.

The company has passion for patients who are in need and this is what fueled its dedication to fill the therapeutic void with hope for the future. RNA is the basis of the discovery platform of Ionis Pharmaceuticals and it has made it possible to bring therapeutic options to patients who otherwise would have none.

The company's antisense therapies have been designed to interact with RNA, enabling them to develop treatments that disrupt the disease process and change its course. Considering its three approved best- and first-in-class medicines and 10+ in mid- or late-stage development, its therapeutic breakthroughs are positioned to continue to change the future of patients in the coming years.

Ionis Pharmaceuticals is a company that operates as an innovator in RNA-targeted therapeutics. The company was designed to create a better, more efficient drug discovery platform, establish a new innovation-centered business model, maximize the value of medicine it creates and gets it to the people who need mostly need it as fast and efficient as possible.

The company has passion for patients who are in need and this is what fueled its dedication to fill the therapeutic void with hope for the future. RNA is the basis of the discovery platform of Ionis Pharmaceuticals and it has made it possible to bring therapeutic options to patients who otherwise would have none.

The company's antisense therapies have been designed to interact with RNA, enabling them to develop treatments that disrupt the disease process and change its course. Considering its three approved best- and first-in-class medicines and 10+ in mid- or late-stage development, its therapeutic breakthroughs are positioned to continue to change the future of patients in the coming years.